SBA Advocacy Office Joins Industry In Opposing AER Labeling Guidance
This article was originally published in The Tan Sheet
Executive Summary
FDA should "better analyze the possible effects" its adverse event reporting draft guidance will have on the dietary supplement industry, according to the Small Business Administration's independent Office of Advocacy
You may also be interested in...
FDA Estimates Dollar Costs For Adverse Event Labeling But Doubts Persist
FDA's estimate of nearly $44 million for the dietary supplement industry to revise labels to comply with the adverse event reporting law may understate the actual burden by leaving out some key costs
FDA Estimates Dollar Costs For Adverse Event Labeling But Doubts Persist
FDA's estimate of nearly $44 million for the dietary supplement industry to revise labels to comply with the adverse event reporting law may understate the actual burden by leaving out some key costs
FDA Estimates Dollar Costs For Adverse Event Labeling But Doubts Persist
FDA's estimate of nearly $44 million for the dietary supplement industry to revise labels to comply with the adverse event reporting law may understate the actual burden by leaving out some key costs